CAR-TCR

Harnessing Disruptive CAR & TCR Based Cell Technologies to Supercharge Safe, Effective & Globally Accessible Cell Immunotherapies in Oncology & Beyond.

The 6th Annual CAR-TCR Summit returns in 2021 as the industry-leading comprehensive forum with one goal: to engineer a disease-free world.
August 30-September 2, 2021 | Digital - EDT

Latest from CAR-TCR

Poseida’s CAR-T Cell Therapy for Prostate Cancer Shows Promising Durable Response in Phase 1

September 01, 2021

Article

The early-phase data readout follows news that the FDA recently approved its IND for its CAR-T candidate in multiple myeloma.

2021 CAR-TCR Summit Elevates Industry Expertise in Cell Therapies

August 27, 2021

Article

The 4-day virtual conference will feature plenary presentations, workshops, and bootcamps led by cell therapy industry leaders with expertise in discovery, development, manufacturing, and more.